We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Committee: Randomized Trials Needed for Accelerated Approvals
Committee: Randomized Trials Needed for Accelerated Approvals
February 16, 2011
Drugmakers conducting postmarket clinical trials should be required to conduct randomized trials, according to the FDA’s Oncologic Drugs Advisory Committee.